Education
About Us
Working with TipRanks
Follow Us
SCOR SE (ADR) (SCRYY)
:SCRYY
Top Page
SCOR SE
(OTC:SCRYY)
66Neutral
SCOR SE (SCRYY) vs. S&P 500 (SPY)
Market Cap
$5.00B
Dividend Yield4.64%
Average Volume (3M)56.13K
Price to Earnings (P/E)1260.9
Beta (1Y)0.92
Revenue Growth1.25%
EPS Growth-107.96%
CountryUS
Employees3,590
SectorFinancial
Sector Strength77
IndustryInsurance
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,795,721,900
10 Day Avg. Volume26,473
30 Day Avg. Volume56,127
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SCOR SE Business Overview & Revenue Model
Company DescriptionSCOR SE (SCRYY) is a leading global reinsurance company headquartered in Paris, France. It operates in two main business sectors: Life & Health reinsurance and Property & Casualty reinsurance. The company provides reinsurance solutions to help clients manage their risk exposure, primarily offering products and services that cover life, health, and non-life insurance sectors. SCOR SE aims to develop customized financial solutions that help insurance companies improve their financial performance and strategic capabilities.
How the Company Makes MoneySCOR SE makes money primarily by providing reinsurance services to insurance companies worldwide. Its revenue model is based on premiums collected from these companies in exchange for assuming a portion of their risk. The company's key revenue streams include life and health reinsurance, which involves covering risks associated with mortality, morbidity, longevity, and health issues, and property and casualty reinsurance, which covers risks related to property damage, natural disasters, and liability claims. SCOR SE also benefits from investment income generated from the premiums it holds in reserve until claims are paid. Strategic partnerships with insurance firms and strong risk management practices contribute significantly to the company's earnings by enhancing its ability to underwrite a wide range of risks effectively.
SCOR SE Financial Statement Overview
Summary
SCOR SE demonstrates strong profitability recovery with a net income of €812M and high gross profit margins, indicating effective cost control. However, slight revenue contraction and asset base reduction present potential risks. The balance sheet is stable with a reasonable debt-to-equity ratio, and cash flow performance is robust, enhancing financial flexibility.Income Statement
SCOR SE shows a strong recovery in profitability with a net income of €812M in 2023 compared to a loss in 2022, driven by improved revenue management. The gross profit margin is notably high, indicating effective cost control. However, revenue growth is slightly negative, which could pose a challenge if the trend continues. EBIT and EBITDA margins have improved significantly, reflecting a rebound in core operating performance.75
Positive
Balance Sheet
The company's balance sheet shows a healthy equity ratio of approximately 13.2% in 2023, indicating a stable financial structure. The debt-to-equity ratio is reasonable at 0.69, suggesting manageable leverage levels. Return on equity has rebounded to 17.3% in 2023, highlighting improved shareholder returns. However, total assets have decreased, which may affect future asset-driven growth.70
Positive
Cash Flow
SCOR SE's cash flow performance is robust, with a strong free cash flow growth rate and operating cash flow significantly exceeding net income, indicating high-quality earnings. The free cash flow to net income ratio is favorable, suggesting efficient cash conversion. The company has maintained positive free cash flow over multiple years, enhancing financial flexibility.80
Positive
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 17.63B | 16.27B | 16.31B | 16.03B | 15.42B | 15.03B | Gross Profit |
| 19.87B | 16.80B | 16.31B | 16.03B | 15.42B | 15.03B | EBIT |
| 665.00M | 1.37B | -1.00M | 645.00M | 311.00M | 510.00M | EBITDA |
| -56.00M | 1.59B | 231.00M | 1.10B | 442.00M | 685.00M | Net Income Common Stockholders |
| 197.00M | 812.00M | -302.00M | 456.00M | 234.00M | 422.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 1.85B | 20.90B | 20.54B | 22.43B | 20.34B | 20.52B | Total Assets |
| 35.48B | 35.48B | 55.33B | 51.52B | 46.22B | 46.88B | Total Debt |
| 3.09B | 3.24B | 3.29B | 3.22B | 3.02B | 2.93B | Net Debt |
| 1.24B | 1.59B | 1.46B | 1.14B | 1.22B | 1.49B | Total Liabilities |
| 3.09B | 30.75B | 50.20B | 45.12B | 40.04B | 40.50B | Stockholders Equity |
| 4.69B | 4.69B | 5.10B | 6.38B | 6.16B | 6.35B |
| Cash Flow | Free Cash Flow | ||||
| 1.45B | 1.45B | 430.00M | 2.32B | 853.00M | 711.00M | Operating Cash Flow |
| 1.47B | 1.48B | 500.00M | 2.41B | 988.00M | 841.00M | Investing Cash Flow |
| -1.11B | -954.00M | -269.00M | -1.54B | -464.00M | -219.00M | Financing Cash Flow |
| -425.00M | -428.00M | -567.00M | -674.00M | -41.00M | -373.00M |
SCOR SE Technical Analysis
Positive
2.78
Price Trends
2.62
Positive
2.48
Positive
2.42
Positive
Market Momentum
0.05
Negative
57.19
Neutral
59.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCRYY, the sentiment is Positive. The current price of 2.78 is above the 20-day moving average (MA) of 2.73, above the 50-day MA of 2.62, and above the 200-day MA of 2.42, indicating a bullish trend. The MACD of 0.05 indicates Negative momentum. The RSI at 57.19 is Neutral, neither overbought nor oversold. The STOCH value of 59.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCRYY.
SCOR SE Peers Comparison
Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $34.05B | 8.11 | 22.02% | ― | 26.24% | -3.87% | |
73 Outperform | $23.44B | 9.22 | 16.52% | ― | 5.17% | 35.36% | |
73 Outperform | $11.79B | 6.86 | 18.40% | 0.65% | 28.22% | -31.48% | |
71 Outperform | $48.61B | 16.10 | 7.10% | 1.90% | -28.56% | 1.14% | |
66 Neutral | $5.00B | 1,260.91 | -4.93% | 4.64% | 1.25% | -107.96% | |
65 Neutral | $5.13B | 26.36 | 6.82% | 1.73% | 15.35% | -44.64% | |
64 Neutral | $13.80B | 10.64 | 9.23% | 4.22% | 17.66% | -7.66% |
* Financial Sector Average
Performance Comparison
SCRYY
SCOR SE
2.81
-0.25
-8.17%
AIG
American International Group
81.63
7.33
9.87%
ACGL
Arch Capital Group
90.09
3.63
4.20%
MKL
Markel
1,827.11
328.48
21.92%
RNR
Renaissancere Holdings
239.41
4.90
2.09%
SIGI
Selective Insurance Group
83.68
-18.95
-18.46%
SCOR SE Earnings Call Summary
Earnings Call Date: Mar 5, 2025 | % Change Since: 0.72% | Next Earnings Date: May 7, 2025
Earnings Call Sentiment Neutral
The quarter showed strong performance in P&C and investment returns, indicating resilience and strategic growth. However, challenges remain in the Life & Health sector and the overall economic value decline, which tempers the positive aspects.Highlights
Strong P&C Performance
P&C combined ratio for 2024 was 86.3%, better than the Forward 2026 assumption of 87%, driven by excellent attritional performance and a low nat cat ratio of 9.4%.
Increased Group Solvency Ratio
The group solvency ratio increased to 210%, a 7-point increase from Q3 2024 and 1 point higher than the end of 2023, demonstrating balance sheet resilience.
Successful P&C Renewals
P&C renewals grew by 9.6% at stable and attractive net combined ratios, leveraging SCOR's Tier 1 franchise.
Elevated Investment Returns
Investments achieved an elevated return with a regular income yield of 3.5%, benefiting from high reinvestment rates.
Lowlights
Negative Life & Health Full Year Result
The Life & Health sector showed a full year negative result, impacted by the 2024 assumption review, with an insurance service result of minus €348 million.
Economic Value Decline
SCOR's group economic value decreased by 6.3% at constant economics, with a full year return on equity at 0.2%.
Impact from Los Angeles Fire
The Los Angeles fire had an impact of €140 million on SCOR, representing 25% of the annual cat budget.
High Expense Variance in Life & Health
Life & Health experienced a negative expense variance, particularly from the U.S., impacting the overall performance.
Company Guidance
In the SCOR Fourth Quarter 2024 Results Conference Call, several key metrics and financial highlights were discussed. SCOR reported a Q4 net income of €233 million, turning the full-year results positive despite the impact from a Life & Health review. Without the review, the group's full-year net income would have been €728 million, translating to a 14.9% return on equity (ROE). The group solvency ratio increased to 210%, up 7 points from Q3 and 1 point higher than the end of 2023, indicating resilience in the balance sheet. The P&C combined ratio for the full year was 86.3%, better than the Forward 2026 assumption of 87%, supported by a strong attritional performance and a 9.4% net cat ratio, below the 10% budget. The Los Angeles Fire was estimated to cost SCOR €140 million, representing 25% of their annual cat budget. The Life & Health segment showed an insurance service result (ISR) of minus €348 million for the year, impacted by the assumption review, though it improved to €119 million in Q4. Investments yielded a 3.5% return for the year, benefiting from high reinvestment rates in a high-quality fixed income portfolio. The Board proposed a dividend of €1.8 per share, aligned with the capital management framework and supported by a robust solvency ratio. SCOR's group economic value stood at €8.6 billion at year-end, down 6.3% at constant economics, yet excluding the Life & Health review, the economic value growth would have been 9.8%. The company also reported success in P&C renewals, with the EGPI growing by 9.6% at stable and attractive net combined ratios.Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.